7
Participants
Start Date
February 28, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Formoterol
Comparison of dosage administered via a nebulizer versus dosage administered via a dry powder inhaler. 12 µg Formoterol with the dry powder inhaler and 20 µg (solution form) of Formoterol with the nebulizer. Patients will receive formoterol and placebo at both study visit #1 and visit #2.
Placebo
Comparison of drug administered via a nebulizer versus a dry powder inhaler. The placebo used will be sterile, preservative free, normal saline for inhalation for the nebulizer and a matched capsule without active drug for the dry powder inhaler. All patients will receive 2 ml of normal saline with the nebulizer to match the volume of nebulized formoterol solution. Patients will receive formoterol and placebo at both study visit #1 and visit #2.
University of Tennessee Medical Center, Knoxville
Mylan Specialty L.P.
UNKNOWN
University of Tennessee Graduate School of Medicine
OTHER